Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
Celldex Therapeutics (NASDAQ:CLDX) announced its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9th, 2025, at 3:20 pm ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Celldex Therapeutics (NASDAQ:CLDX) announced its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9th, 2025, at 3:20 pm ET.
Investors can access a live webcast of the presentation through the "Events & Presentations" page in the "Investors" section of Celldex's website. The presentation recording will remain available for 90 days after the event.
Details
News Market Reaction – CLDX
On Sep 9, the day this news came out, CLDX closed 3.85% above the previous close.
Data tracked by StockTitan Argus for the Sep 9 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025, at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm ET. A live webcast of the presentation will be available on the "Events & Presentations” page of the "Investors" section of the Celldex website. A replay will be available for 90 days following the event.
About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.